Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
266.57
+10.01 (3.90%)
Dec 20, 2024, 4:00 PM EST - Market closed
Insulet Employees
Insulet had 3,000 employees as of December 31, 2023. The number of employees increased by 400 or 15.38% compared to the previous year.
Employees
3,000
Change (1Y)
400
Growth (1Y)
15.38%
Revenue / Employee
$661,300
Profits / Employee
$140,300
Market Cap
18.70B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3,000 | 400 | 15.38% |
Dec 31, 2022 | 2,600 | 300 | 13.04% |
Dec 31, 2021 | 2,300 | 400 | 21.05% |
Dec 31, 2020 | 1,900 | 550 | 40.74% |
Dec 31, 2019 | 1,350 | 181 | 15.48% |
Dec 31, 2018 | 1,169 | 312 | 36.41% |
Dec 31, 2017 | 857 | 217 | 33.91% |
Dec 31, 2016 | 640 | -7 | -1.08% |
Dec 31, 2015 | 647 | 128 | 24.66% |
Dec 31, 2014 | 519 | 41 | 8.58% |
Dec 31, 2013 | 478 | -60 | -11.15% |
Dec 31, 2012 | 538 | -38 | -6.60% |
Dec 31, 2011 | 576 | 266 | 85.81% |
Dec 31, 2010 | 310 | 34 | 12.32% |
Dec 31, 2009 | 276 | -18 | -6.12% |
Dec 31, 2008 | 294 | 47 | 19.03% |
Dec 31, 2007 | 247 | -47 | -15.99% |
Dec 31, 2006 | 294 | 47 | 19.03% |
Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Labcorp Holdings | 67,000 |
Quest Diagnostics | 48,000 |
ICON Public Limited Company | 41,100 |
STERIS | 18,179 |
Molina Healthcare | 18,000 |
The Cooper Companies | 15,000 |
BeiGene | 10,600 |
Hologic | 6,990 |
PODD News
- 16 days ago - Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case - Reuters
- 17 days ago - Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Business Wire
- 4 weeks ago - Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines - Seeking Alpha
- 4 weeks ago - Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S. - Business Wire
- 5 weeks ago - Insulet to Present at Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Buy, Sell, Or Hold Insulet (PODD) Stock? - Forbes
- 5 weeks ago - Top 4 Health Care Stocks That May Plunge This Quarter - Benzinga
- 6 weeks ago - Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript - Seeking Alpha